# Titan Biotech Ltd (TITANBIO)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹472.55
Day Change: -1.93%
52W High: ₹555.65
52W Low: ₹74.73
Market Cap: ₹1,871 Cr

## Valuation
P/E: 68.93
P/B: 11.24
EPS: ₹6.57
Book Value: ₹40.29
Dividend Yield: 9%

## Returns
1Y Return: 415.72%

## Profitability
ROE: 15.28%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Titan Biotech Ltd is a Biotechnology company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Biotechnology
Sub Industry: Unknown

## Business Model
Overview: Titan Biotech Ltd makes money through Technology services, Digital transformation projects, Maintenance and managed services in Biotechnology. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Technology services
- Digital transformation projects
- Maintenance and managed services
Operating Model:
- Wins client contracts, deploys skilled delivery teams, and earns project or recurring service revenue.
- Utilisation, billing rates, attrition, and currency movements are key operating levers.
Recent Context:
- Announcement: Intimation Regarding Second 100 Days Campaign - 'Saksham Niveshak'
- Announcement: Announcement under Regulation 30 (LODR)-Press Release / Media Release
- BSE Filing: Intimation Regarding Second 100 Days Campaign - 'Saksham Niveshak'

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-25T05:15:19.642Z
Price History Updated: 2026-05-26T02:01:19.431Z
Latest Price History Date: 2026-05-25
Technicals Updated: 2026-05-26T02:01:19.431Z
Quant Updated: 2026-05-26T02:01:19.431Z
Sentiment Updated: 2026-05-26T02:01:19.431Z
Financials Status: current
Financials Updated: 2026-05-18T09:30:01.601Z
Financials Last Attempt: 2026-05-18T09:30:01.601Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2016)
Revenue: ₹40 Cr
Operating Profit: ₹4 Cr (OPM 10%)
Net Profit: ₹2 Cr
Tax: ₹2 Cr

## Annual P&L History
Mar 2016: Rev ₹40Cr | PAT ₹2Cr | OPM 10%
Mar 2017: Rev ₹46Cr | PAT ₹2Cr | OPM 9%
Mar 2018: Rev ₹53Cr | PAT ₹2Cr | OPM 10%

## Balance Sheet (Mar 2016)
Total Assets: ₹34 Cr
Total Liabilities: ₹34 Cr
Borrowings: ₹8 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/titanbio
Disclaimer: For research and education only. Not investment advice.